143 related articles for article (PubMed ID: 10693951)
1. Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome.
Sendera TJ; Ma SY; Jaffar S; Kozlowski PB; Kordower JH; Mawal Y; Saragovi HU; Mufson EJ
J Neurochem; 2000 Mar; 74(3):1185-96. PubMed ID: 10693951
[TBL] [Abstract][Full Text] [Related]
2. Galaninergic innervation of the cholinergic vertical limb of the diagonal band (Ch2) and bed nucleus of the stria terminalis in aging, Alzheimer's disease and Down's syndrome.
Mufson EJ; Cochran E; Benzing W; Kordower JH
Dementia; 1993; 4(5):237-50. PubMed ID: 7505157
[TBL] [Abstract][Full Text] [Related]
3. Degeneration of the basalocortical pathway from the cortex induces a functional increase in galaninergic markers in the nucleus basalis magnocellularis of the rat.
Barbelivien A; Vaussy C; Marchalant Y; Maubert E; Bertrand N; Beley A; Roussel S; Mackenzie ET; Dauphin F
J Cereb Blood Flow Metab; 2004 Nov; 24(11):1255-66. PubMed ID: 15545921
[TBL] [Abstract][Full Text] [Related]
4. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.
Mufson EJ; Ma SY; Cochran EJ; Bennett DA; Beckett LA; Jaffar S; Saragovi HU; Kordower JH
J Comp Neurol; 2000 Nov; 427(1):19-30. PubMed ID: 11042589
[TBL] [Abstract][Full Text] [Related]
5. Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis.
Mufson EJ; Deecher DC; Basile M; Izenwasse S; Mash DC
Neuropharmacology; 2000 Jun; 39(8):1404-12. PubMed ID: 10818256
[TBL] [Abstract][Full Text] [Related]
6. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.
Mufson EJ; Lavine N; Jaffar S; Kordower JH; Quirion R; Saragovi HU
Exp Neurol; 1997 Jul; 146(1):91-103. PubMed ID: 9225742
[TBL] [Abstract][Full Text] [Related]
7. Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease.
Counts SE; Chen EY; Che S; Ikonomovic MD; Wuu J; Ginsberg SD; Dekosky ST; Mufson EJ
Dement Geriatr Cogn Disord; 2006; 21(4):205-14. PubMed ID: 16410678
[TBL] [Abstract][Full Text] [Related]
8. Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer's disease and Lewy body disorders.
Alexandris AS; Walker L; Liu AKL; McAleese KE; Johnson M; Pearce RKB; Gentleman SM; Attems J
Neuropathol Appl Neurobiol; 2020 Apr; 46(3):264-278. PubMed ID: 31454423
[TBL] [Abstract][Full Text] [Related]
9. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
[TBL] [Abstract][Full Text] [Related]
10. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
Mufson EJ; Jaffar S; Levey AI
J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease.
Counts SE; Che S; Ginsberg SD; Mufson EJ
J Chem Neuroanat; 2011 Oct; 42(2):111-7. PubMed ID: 21397006
[TBL] [Abstract][Full Text] [Related]
12. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease.
Bowser R; Kordower JH; Mufson EJ
Brain Pathol; 1997 Apr; 7(2):723-30. PubMed ID: 9161723
[TBL] [Abstract][Full Text] [Related]
13. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
[TBL] [Abstract][Full Text] [Related]
14. P75 neurotrophin receptor in the nucleus basalis of meynert in relation to age, sex, and Alzheimer's disease.
Salehi A; Ocampo M; Verhaagen J; Swaab DF
Exp Neurol; 2000 Jan; 161(1):245-58. PubMed ID: 10683291
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease.
Chu Y; Cochran EJ; Bennett DA; Mufson EJ; Kordower JH
J Comp Neurol; 2001 Aug; 437(3):296-307. PubMed ID: 11494257
[TBL] [Abstract][Full Text] [Related]
16. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
Gibbs RB
Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
[TBL] [Abstract][Full Text] [Related]
17. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of galaninergic fibers following neurotoxic damage within the rat basal forebrain: initial observations.
de Lacalle S; Kulkarni S; Mufson EJ
Exp Neurol; 1997 Aug; 146(2):361-6. PubMed ID: 9270045
[TBL] [Abstract][Full Text] [Related]
19. Progression of age-associated cognitive impairment correlates with quantitative and qualitative loss of TrkA receptor protein in nucleus basalis and cortex.
Saragovi HU
J Neurochem; 2005 Dec; 95(5):1472-80. PubMed ID: 16219032
[TBL] [Abstract][Full Text] [Related]
20. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease.
Ginsberg SD; Che S; Wuu J; Counts SE; Mufson EJ
J Neurochem; 2006 Apr; 97(2):475-87. PubMed ID: 16539663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
